Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PET as a tool in pharmacologic development]

M Bergström1, P Hartvig, B Långström

  • 1Uppsala Universitet PET-centrum.

Nordisk Medicin
|October 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

News ways of understanding the complex biology of diabetes using PET.

Nuclear medicine and biology·2020
Same author

Increased neurokinin-1 receptor availability in the amygdala in social anxiety disorder: a positron emission tomography study with [11C]GR205171.

Translational psychiatry·2015
Same author

Endogenous compounds labeled with radionuclides of short half-life-some perspectives.

Journal of labelled compounds & radiopharmaceuticals·2013
Same author

Brain activation in young and older adults during implicit and explicit retrieval.

Journal of cognitive neuroscience·2013
Same author

Mao-a enzyme binding in bladder-cancer characterized with [C-11] harmine in frozen-section autoradiography.

Oncology reports·2011
Same author

Occupancy of human brain GABA(A) receptors by the novel α5 subtype-selective benzodiazepine site inverse agonist α5IA as measured using [¹¹C]flumazenil PET imaging.

Neuropharmacology·2010
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

Positron emission tomography (PET) provides valuable in vivo data on tracer distribution and concentration. This technique is crucial for early clinical trials in drug development, aiding in dosing decisions.

Area of Science:

  • Nuclear medicine
  • Pharmacokinetics
  • Radiochemistry

Context:

  • Positron emission tomography (PET) enables in vivo measurement of tracer compounds.
  • PET imaging offers insights into anatomical distribution, time course, and absolute concentration of tracers.
  • These capabilities are highly beneficial in pharmaceutical research and development.

Purpose:

  • To highlight the utility of PET in drug development.
  • To explain how PET assesses drug kinetics and target interactions.
  • To demonstrate PET's role in optimizing dosing regimens.

Summary:

  • PET imaging allows for the in vivo recording of tracer compounds, detailing their anatomical distribution, temporal changes, and concentration.
  • This methodology is particularly valuable in early-phase clinical trials for drug development.

Related Experiment Videos

  • It facilitates the assessment of tissue kinetics and drug-target interactions, informing dosing strategies.

    • Impact:

    • PET imaging significantly aids in making informed decisions regarding drug dosing.
    • It enhances the efficiency and accuracy of early-stage drug development processes.
    • Provides critical data for evaluating drug efficacy and safety profiles in vivo.